Paget’s Disease :: Reclast receives US approval as a treatment for patients with Paget’s disease of bone
Reclast? (zoledronic acid) has received US regulatory approval as the first new treatment in nearly a decade for patients with a bone condition known as Paget’s disease, estimated to affect about one million people in the US alone.